Working… Menu
Trial record 1 of 1 for:    NCT02631044
Previous Study | Return to List | Next Study

Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02631044
Recruitment Status : Recruiting
First Posted : December 15, 2015
Last Update Posted : November 4, 2019
Information provided by (Responsible Party):
Juno Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020